Genetic Signatures Limited announced earnings results for the half year ended December 31, 2020. For the half year, the company announced sales was AUD 18.928 million compared to AUD 3.704 million a year ago. Net income was AUD 4.497 million compared to net loss of AUD 2.346 million a year ago. Basic earnings per share from continuing operations was AUD 0.0315 compared to basic loss per share from continuing operations of AUD 0.021 a year ago. Diluted earnings per share from continuing operations was AUD 0.0309 compared to diluted loss per share from continuing operations of AUD 0.021 a year ago.